SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-007973
Filing Date
2018-10-29
Accepted
2018-10-29 16:04:11
Documents
42
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mrns-20180930x10q.htm 10-Q 1070500
2 EX-31.1 mrns-20180930ex31179fbd0.htm EX-31.1 15231
3 EX-31.2 mrns-20180930ex312aebab0.htm EX-31.2 15374
4 EX-32.1 mrns-20180930ex321494185.htm EX-32.1 9458
5 GRAPHIC mrns20180930x10q001.jpg GRAPHIC 23678
  Complete submission text file 0001558370-18-007973.txt   2980928

Data Files

Seq Description Document Type Size
6 EX-101.INS mrns-20180930.xml EX-101.INS 481280
7 EX-101.SCH mrns-20180930.xsd EX-101.SCH 17682
8 EX-101.CAL mrns-20180930_cal.xml EX-101.CAL 28987
9 EX-101.DEF mrns-20180930_def.xml EX-101.DEF 57015
10 EX-101.LAB mrns-20180930_lab.xml EX-101.LAB 206795
11 EX-101.PRE mrns-20180930_pre.xml EX-101.PRE 136831
Mailing Address 170 N RADNOR CHESTER RD SUITE 250 RADNOR PA 19087
Business Address 170 N RADNOR CHESTER RD SUITE 250 RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS INC (Filer) CIK: 0001267813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36576 | Film No.: 181144250
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences